Investor Presentation November 2022 Second Quarter Fiscal Year 2025 Supplemental Presentation May 5, 2025 Cautionary Statement Regarding Forward-Looking Statements Certain matters discussed in this presentation and the accompanying oral presentation are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made based on known events and circumstances at the time of presentation, and as such, are subject to uncertainty and ...

Core Insights - BellRing Brands, Inc. reported strong financial results for the second fiscal quarter ended March 31, 2025, with net sales reaching $588.0 million, an increase of 18.9% year-over-year, driven by volume growth and price/mix improvements [4][10][15]. Financial Performance - Adjusted EBITDA for the second quarter was $118.6 million, reflecting a 14.4% increase compared to the prior year [14]. - Gross profit was $189.8 million, or 32.3% of net sales, up 15.5% from $164.3 million, or 33.2% of net sales, in the previous year [7][34]. - Selling, general and administrative (SG&A) expenses increased to $90.5 million, representing 15.4% of net sales, compared to $69.1 million, or 14.0% of net sales, in the prior year [9][18]. Product Performance - Premier Protein net sales increased by 22.0%, driven by a 15.3% volume growth and a 6.7% increase in price/mix [5][15]. - Dymatize net sales grew by 3.0%, with a significant 20.4% increase in volume, although this was partially offset by a 17.3% decrease in price/mix [6][15]. Market Trends - The consumption of Premier Protein ready-to-drink shakes and powder products saw increases of 24.9% and 21.7%, respectively, indicating strong market demand [3]. - The company continues to expect net sales growth of 13% to 17% for fiscal year 2025, despite macroeconomic uncertainties [3][24]. Share Repurchase Activity - During the second quarter, BellRing repurchased 2.4 million shares for $171.7 million at an average price of $71.68 per share, with $280.0 million remaining under its share repurchase authorization as of March 31, 2025 [23]. Outlook - The company has affirmed its fiscal year 2025 outlook, expecting net sales to range between $2.26 billion and $2.34 billion, and Adjusted EBITDA to range between $470 million and $500 million [24].